MedPath logo

TAFLOTAN-S OPHTHALMIC SOLUTION 0.0015%

Prescription Only
Drug type: Therapeutic
ATC code: S01EE05
Dosage form: SOLUTION, STERILE
Route of administration: OPHTHALMIC
Active ingredient: Tafluprost; TAFLUPROST

Indications

Reduction of intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension.

Contraindications (This product is contraindicated in the following patients.)

Patients with a history of hypersensitivity to any of the ingredients of this product. Patients with combination with products containing omidenepag isopropyl.

Dosage and Administration

Instill 1 drop in the affected eye(s) once daily.

Do not use more than once daily because more frequent administration may lessen the IOP-lowering effect.

Registrant
SANTEN PHARMACEUTICAL ASIA PTE. LTD.
Approval Date
2015-09-23
Approval Number
SIN14856P
Manufacturer
Santen Pharmaceutical Co Ltd (Noto Plant)
Licence Holder
SANTEN PHARMACEUTICAL ASIA PTE. LTD.